CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity and mortality) 2 Yr Placebo run-in (2-6 wk)  Placebo-controlled, multicenter, randomized, double-blind, comparative, parallel trial Enalapril mg Amlodipine 5-10 mg Placebo PCI indicates percutaneous coronary intervention.
{}